2023 annual financial data

Verrica Pharmaceuticals 2023 Financial results

Direct answer

Revenue was 5,124,000 USD.

Operating income was -65,759,000 USD and net income was -66,995,000 USD.
Operating cash flow was -38,577,000 USD.

Get free Verrica Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
5,124,000 USD
Operating income
-65,759,000 USD
Net income
-66,995,000 USD
Operating cash flow
-38,577,000 USD